Constitutive activation of STAT3 has been described in hematopoietic disorders such as myeloma, Hodgkin lymphoma, anaplastic large cell lymphoma (ALK), angioimmunoblastic T cell lymphoma, adult T cell lymphoma/leukemia, and mantle lymphoma [19,20]. This evidence concerns the gene STAT3 and plasma cell myeloma.